Beta Drugs Reports Audited Financial Results For Fy26 Targets 80 Own
Beta Drugs Reports Audited Financial Results for FY26, Targets 80% Own ...
Virinchi Limited Reports Audited Q4 and FY26 Financial Results
KIMS Hospitals Announces Audited Financial Results for Q4 FY26 and ...
Kabra Drugs publishes audited results for FY26
WeP Solutions Reports FY26 Annual Audited Standalone Financial Results ...
Gretex Industries Reports FY26 Audited Financial Results
Beta Drugs Q4 FY26 Results Preview and Earnings Outlook
Aditya Birla Money Approves Audited Financial Results for FY 2026
Beta Drugs conducted the conference call for Q4 FY22. "Mgmt targets to ...
Solara Active Pharma Sciences Releases Audited Financial Results for FY ...
Advertisement Space (300x250)
Macfos Limited Resubmits Consolidated Audited Financial Results for ...
Beta Glass Plc Full-Year Audited Financial Report for the Period Ended ...
Beta Drugs conducted the conference call for Q4 FY22. "Mgmt targets to ...
Anmol India Limited Announces Audited Standalone Financial Results for ...
IGL, in its Audited Financial Results for FY 2023-24, showcased a ...
AVI Polymers Ltd Reports Landmark Turnaround with Audited FY26 Results ...
Abans Financial Services Reports FY26 Audited Results; Publishes in ...
Beta Glass PLC Audited Financial Statement For 2021 F | PDF
Beta Drugs conducted the conference call for Q4 FY22. "Mgmt targets to ...
Macfos Limited Resubmits Consolidated Audited Financial Results for ...
Advertisement Space (336x280)
Audited Financial Results Standalone For FY 2024 | PDF
Beta Drugs Targets Vision 2030 Revenue Expansion; Expects Strong Export ...
Beta Drugs Ltd Q2 FY25 Financial Results: Key Highlights and Insights ...
Beta Drugs Limited Q3 FY26 Results:- #Q3Results #Q3FY26 #Stockmarket # ...
Beta Drugs H1FY25 Results: Strong Growth | PDF | Expense | Financial ...
Akums Drugs and Pharmaceuticals Q3 Results FY26 Preview: PAT to fall 0.04%
Oriana Power Reports Audited FY26 Results, Highlights Expansion in ...
BETA GLASS ANNUAL RERPORT AND AUDITED FINANCIAL 2022
Beta Drugs Q4 FY26 Concall: Strategy to Scale Branded Oncology ...
Beta Drugs Ltd FY25 Results | 23% Revenue Growth🚀Concall Highlights ...
Advertisement Space (336x280)
Prabhu Steel Industries Reports FY26 Audited Results; PAT Turns ...
Beta Glass Plc 4th Quarter Unaudited Financial Report for the Period ...
Beta Drugs Targets Vision 2030 Revenue Expansion; Expects Strong Export ...
Dynamic Portfolio Submits FY26 Audited Results Publication
Beta Drugs Share Price Target 2026 Analyst Forecast Bull and Bear Case
Beta Drugs Q4 FY26: PAT Rs 3.00 Crore